US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cullinan Therapeutics

8.52

+0.24002.90%

Post-market: 8.520.00000.00%18:54 EDT

Volume:457.13K

Turnover:3.84M

Market Cap:498.53M

PE:-2.74

High:8.59

Open:8.28

Low:8.07

Close:8.28

Loading ...

Overview Company News Filings

BRIEF-Cullinan Oncology Q4 Pretax Profit USD -47.53 Million

Cullinan Oncology Q4 Operating Expenses USD 55.048 Million

THOMSON REUTERS

Cullinan Therapeutics Inc: Qtrly Loss per Share $0.73

THOMSON REUTERS

Cullinan Therapeutics: Cash and Investments of $606.9 Mln as of Dec 31, 2024, Continues to Provide Runway Into 2028

THOMSON REUTERS

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Cullinan Therapeutics (NASDAQ:CGEM) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Positive Phase 2b Trial Results Drive Price Target Revision and Future Growth Prospects for NSCLC Treatment

Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co.

Cullinan Management Receives ‘Buy’ Rating as Phase 2b Study Success and Taiho Partnership Boost Prospects

Cullinan Therapeutics price target raised to $33 from $28 at H.C. Wainwright

Positive Buy Rating for Cullinan Management Driven by Zipalertinib’s Promising Efficacy and Strategic Partnership with Taiho Oncology

Cullinan Management (CGEM) Receives a Buy from Wedbush

Cullinan Management (CGEM) Gets a Buy from TD Cowen

Cullinan Therapeutics Says Zipalertinib Trial Met Primary Endpoint

MT Newswires Live

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Top Premarket Decliners

MT Newswires Live

Cullinan Management (CGEM) Has a New Rating from Wedbush

U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CGEM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEM\",,,,,undefined,":{"symbol":"CGEM","market":"US","secType":"STK","nameCN":"Cullinan Therapeutics","latestPrice":8.52,"timestamp":1746129600000,"preClose":8.28,"halted":0,"volume":457132,"hourTrading":{"tag":"盘后","latestPrice":8.52,"preClose":8.52,"latestTime":"18:54 EDT","volume":10318,"amount":87911.08,"timestamp":1746140060011},"delay":0,"floatShares":38980846,"shares":58512826,"eps":-3.112886,"marketStatus":"Closed","change":0.24,"latestTime":"05-01 16:00:00 EDT","open":8.28,"high":8.59,"low":8.07,"amount":3835822.8817,"amplitude":0.062802,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.112886,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746172800000},"marketStatusCode":5,"adr":0,"listingDate":1610082000000,"exchange":"NASDAQ","adjPreClose":8.28,"preHourTrading":{"tag":"盘前","latestPrice":8.29,"preClose":8.28,"latestTime":"09:29 EDT","volume":208,"amount":1694.040088,"timestamp":1746106199999},"postHourTrading":{"tag":"盘后","latestPrice":8.52,"preClose":8.52,"latestTime":"18:54 EDT","volume":10318,"amount":87911.08,"timestamp":1746140060011},"volumeRatio":1.730682,"impliedVol":1.2472,"impliedVolPercentile":0.892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGEM\",,,,,undefined,":{"symbol":"CGEM","floatShares":38980846,"roa":"-22.26%","roe":"-32.10%","lyrEps":-3.112886,"volumeRatio":1.730682,"shares":58512826,"dividePrice":0,"high":8.59,"amplitude":0.062802,"preClose":8.28,"low":8.07,"week52Low":6.85,"pbRate":"0.84","week52High":30.1886,"institutionHeld":0,"latestPrice":8.52,"eps":-3.112886,"divideRate":0,"volume":457132,"delay":0,"ttmEps":-3.112886,"open":8.28,"prevYearClose":12.18,"prevWeekClose":8.14,"prevMonthClose":8.28,"prevQuarterClose":7.57,"fiveDayClose":8.14,"twentyDayClose":7.82,"sixtyDayClose":10.2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGEM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514058798","title":"BRIEF-Cullinan Oncology Q4 Pretax Profit USD -47.53 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514058798","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514058798?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:01","pubTimestamp":1740657677,"startTime":"0","endTime":"0","summary":"BRIEF-Cullinan Oncology Q4 Pretax Profit USD -47.53 Million\n\n\nFeb 27 (Reuters) - Cullinan Oncology Q4 operating expenses USD 55.048 million.\n\nQ4 operating income USD -55.048 million\nQ4 net income USD -47.647 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX82794C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2514805359","title":"Cullinan Oncology Q4 Operating Expenses USD 55.048 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514805359?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX82794C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2514641805","title":"Cullinan Therapeutics Inc: Qtrly Loss per Share $0.73","url":"https://stock-news.laohu8.com/highlight/detail?id=2514641805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514641805?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX82794C:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2514280533","title":"Cullinan Therapeutics: Cash and Investments of $606.9 Mln as of Dec 31, 2024, Continues to Provide Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2514280533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514280533?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX82794C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2514180530","title":"Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180530","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514180530?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"Initial clinical data from global Phase 1 study of CLN-978 in Systemic Lupus Erythematosus  expected in Q4 2025; CLN-978 remains the first and only development-stage CD19 T cell engager in an autoimmune disease clinical trial in the U.S.Zipalertinib pivotal Phase 2b study met primary endpoint; full results mid-year 2025 and NDA submission planned H2 2025, pending regulatory discussions. Cash and investments of $606.9 million as of December 31, 2024, continues to provide runway into 2028. CAMBRIDGE, Mass., Feb. 27, 2025  -- Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today reported recent and anticipated business highlights and announced its financial results for the fourth quarter and full year ended December 31, 2024.CLN-978 : Systemic lupus erythematosus and rheumatoid arthritis. The global Phase 1 study in moderate to severe SLE is ongoing with site expansion in the United States, Europe and Australia, and the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-provides-corporate-reports-120000914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","RA","BK4077","SLE","CGEM"],"gpt_icon":0},{"id":"2507969892","title":"Cullinan Therapeutics (NASDAQ:CGEM) Is In A Good Position To Deliver On Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969892","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507969892?lang=en_us&edition=fundamental","pubTime":"2025-01-31 22:46","pubTimestamp":1738334809,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?So should Cullinan Therapeutics  shareholders be worried about its cash burn?For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.When Might Cullinan Therapeutics Run Out Of Money?It may already be apparent to you that we're relatively comfortable with the way Cullinan The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-nasdaq-cgem-good-144649442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","TQQQ","BK4139","BK4588","QLD","NDAQ","QID","IE00BKPKM429.USD","BK4585","SQQQ","IE00B64PRP62.GBP","USAW.SI","USJW.SI","PSQ","LU2210150020.SGD","TSYW.SI","IE00B3QW5Z07.USD","NQmain","IE00BGHQF748.EUR",".IXIC","LU2095319765.USD","MNQmain","BK4112","LU2210149790.SGD","CGEM"],"gpt_icon":1},{"id":"2507642058","title":"Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507642058","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507642058?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:00","pubTimestamp":1738238400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Jan. 30, 2025  -- Cullinan Therapeutics, Inc., a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference, being held in New York on February 5 and 6, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-participate-fireside-chat-120000714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4011","CGEM","SMID","BK4139"],"gpt_icon":0},{"id":"2507420556","title":"Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507420556","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507420556?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:00","pubTimestamp":1738238400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Jan.  30, 2025  (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc.(Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, tod","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/30/3017883/0/en/Cullinan-Therapeutics-to-Participate-in-Fireside-Chat-at-the-Guggenheim-Securities-SMID-Cap-Biotech-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4011","CGEM","SMID","BK4139"],"gpt_icon":0},{"id":"2507161729","title":"Positive Phase 2b Trial Results Drive Price Target Revision and Future Growth Prospects for NSCLC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2507161729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507161729?lang=en_us&edition=fundamental","pubTime":"2025-01-30 16:35","pubTimestamp":1738226125,"startTime":"0","endTime":"0","summary":"Andrew Berens, an analyst from Leerink Partners, assigned the Buy rating on Cullinan Management (CGEM – Research Report). The associated price targ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-phase-2b-trial-results-drive-price-target-revision-and-future-growth-prospects-for-nsclc-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-phase-2b-trial-results-drive-price-target-revision-and-future-growth-prospects-for-nsclc-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGEM"],"gpt_icon":0},{"id":"2507659055","title":"Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2507659055","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507659055?lang=en_us&edition=fundamental","pubTime":"2025-01-30 02:09","pubTimestamp":1738174140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2025 13:09 ET (18:09 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEM"],"gpt_icon":0},{"id":"2507565716","title":"Cullinan Management Receives ‘Buy’ Rating as Phase 2b Study Success and Taiho Partnership Boost Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2507565716","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507565716?lang=en_us&edition=fundamental","pubTime":"2025-01-30 01:15","pubTimestamp":1738170917,"startTime":"0","endTime":"0","summary":"Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Cullinan Management (CGEM – Research Report). The associated price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cullinan-management-receives-buy-rating-as-phase-2b-study-success-and-taiho-partnership-boost-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cullinan-management-receives-buy-rating-as-phase-2b-study-success-and-taiho-partnership-boost-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2507565176","title":"Cullinan Therapeutics price target raised to $33 from $28 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2507565176","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507565176?lang=en_us&edition=fundamental","pubTime":"2025-01-30 01:10","pubTimestamp":1738170629,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Cullinan Therapeutics (CGEM) to $33 from $28 and keeps a Buy rating on the shares after the compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-price-target-raised-to-33-from-28-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cullinan-therapeutics-price-target-raised-to-33-from-28-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2507632896","title":"Positive Buy Rating for Cullinan Management Driven by Zipalertinib’s Promising Efficacy and Strategic Partnership with Taiho Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2507632896","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507632896?lang=en_us&edition=fundamental","pubTime":"2025-01-29 22:55","pubTimestamp":1738162536,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy maintained a Buy rating on Cullinan Management (CGEM – Research Report) today and set a price target of $34.00. Sou...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-buy-rating-for-cullinan-management-driven-by-zipalertinibs-promising-efficacy-and-strategic-partnership-with-taiho-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-buy-rating-for-cullinan-management-driven-by-zipalertinibs-promising-efficacy-and-strategic-partnership-with-taiho-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2507163645","title":"Cullinan Management (CGEM) Receives a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2507163645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507163645?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:56","pubTimestamp":1738158985,"startTime":"0","endTime":"0","summary":"Wedbush analyst Robert Driscoll maintained a Buy rating on Cullinan Management (CGEM – Research Report) today and set a price target of $36.00. The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-receives-a-buy-from-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-receives-a-buy-from-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2507638224","title":"Cullinan Management (CGEM) Gets a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2507638224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507638224?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:56","pubTimestamp":1738155383,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm maintained a Buy rating on Cullinan Management (CGEM – Research Report) today. The company’s shares closed yesterday at...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-gets-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-gets-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM","BK4139","COWN","BK4566","TD","BK4207","BK4585","BK4127"],"gpt_icon":0},{"id":"2507683479","title":"Cullinan Therapeutics Says Zipalertinib Trial Met Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2507683479","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507683479?lang=en_us&edition=fundamental","pubTime":"2025-01-29 17:27","pubTimestamp":1738142879,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics , Taiho Pharmaceutical and Taiho Oncology said late Tuesday a phase 1/2 clinical trial of zipalertinib monotherapy in certain patients with non-small cell lung cancer met its primary endpoint of overall response rate.These results are based on the phase 2b part of the study, and the companies plan to submit for US regulatory approval in the second half of 2025, they said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CGEM","BK4139"],"gpt_icon":0},{"id":"2507578293","title":"Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2507578293","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507578293?lang=en_us&edition=fundamental","pubTime":"2025-01-29 08:00","pubTimestamp":1738108800,"startTime":"0","endTime":"0","summary":"TOKYO, PRINCETON, N.J. and CAMBRIDGE, Mass., Jan. 28, 2025 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., announced today the REZILIENT1 trial, a Phase 1/2 clinical trial of zipalertinib  monotherapy in patients with non-small cell lung cancer  harboring the epidermal growth factor receptor  exon 20 insertion mutations who have received prior therapy, met its primary endpoint of overall response rate. The safety profile was generally consistent with previous data presentations. These results are based on the Phase 2b part of this study.Full results from REZILIENT1 will be submitted for presentation at an upcoming international medical conference. Pending discussions with the U.S. Food and Drug Administration , the companies plan to submit for U.S. regulatory approval in the second half of 2025.About theEGFR exon 20 insertion mutationsNSCLC is a common form of lung cancer and up to 4% of all cases have EGFR exon 20 insertions, whic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/taiho-pharmaceutical-taiho-oncology-cullinan-000000754.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/taiho-pharmaceutical-taiho-oncology-cullinan-000000754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGEM"],"gpt_icon":0},{"id":"2491698277","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2491698277","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491698277?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:51","pubTimestamp":1734353519,"startTime":"0","endTime":"0","summary":"SOBR Safe  shares slumped 34% pre-bell Monday, extending Friday's slide.Zoomcar Holdings  shares fell 27% following a muted session.Cullinan Therapeutics  shares retreated 23% following a 3.7% drop in the previous session.Lensar  shares decreased almost 20% after Friday's 2.1% loss.Astria Therapeutics  shares were down 15% after a 3% drop on Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZCAR","LNSR","BK4230","BK4139","ATXS","SOBR","BK4157","BK4082","CGEM"],"gpt_icon":0},{"id":"2484947615","title":"Cullinan Management (CGEM) Has a New Rating from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2484947615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484947615?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:05","pubTimestamp":1732025112,"startTime":"0","endTime":"0","summary":"Cullinan Management (CGEM – Research Report) received a Buy rating and a $36.00 price target from Wedbush analyst Robert Driscoll today. The compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-has-a-new-rating-from-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cullinan-management-cgem-has-a-new-rating-from-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGEM"],"gpt_icon":0},{"id":"2484096038","title":"U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484096038","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484096038?lang=en_us&edition=fundamental","pubTime":"2024-11-19 15:10","pubTimestamp":1732000202,"startTime":"0","endTime":"0","summary":"Nov 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Equifax, Microstrategy and Netflix, on Tuesday.  HIGHLIGHTS      ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOM","FNV","NFLX","CHPT","ARVN","CASY","MSTR","LU0106831901.USD","LU0109394709.USD","FTNT","ACRS","LU2237957902.USD","CPRX","PTCT","RC","BK4113","FENC","QS","LU1429558221.USD","EFX","MOS","LU1571399168.USD","BK4107","IDYA","BK4585","LU2326559502.SGD","CGEM","VRT","EHAB","PANW","KHC","RGNX","LOVE","LU2249611893.SGD","IE00BQXX3C00.GBP","KMPR","MEOH","WSM","HSBC","KYMR","LU1046421795.USD","CPRT","CCCC","LU0106261372.USD","BECN"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"CGEM","fiscalQuarterEnding":"2024/12","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2024-11-07","symbol":"CGEM","fiscalQuarterEnding":"2024/09","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.69},{"market":"US","date":"2024-08-08","symbol":"CGEM","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2024-05-15","symbol":"CGEM","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.86},{"market":"US","date":"2024-03-14","symbol":"CGEM","fiscalQuarterEnding":"2023/12","expectedEps":-0.96,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710388800000,"reportTimeType":"pre","actualEps":-0.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1729742400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGEM","date":"2025-04-30","current":-2.761638,"percent":0.700095,"low":-82.322021,"twenty":-16.637784,"median":-5.312771,"eighty":3.853025,"high":8.073957,"avg":-9.12231,"sd":15.639655,"marketCap":462251325},"quantilePoints":[{"date":"2021-01-08","current":-42.159039,"twenty":-39.647257,"median":-35.879584,"eighty":-32.11191,"marketCap":1181380603},{"date":"2021-01-15","current":-54.059463,"twenty":-54.429311,"median":-43.714306,"eighty":-41.524085,"marketCap":1514854272},{"date":"2021-01-22","current":-59.329798,"twenty":-58.297306,"median":-54.059463,"eighty":-42.159039,"marketCap":1662539609},{"date":"2021-01-29","current":-58.574692,"twenty":-58.836668,"median":-57.842701,"eighty":-43.714306,"marketCap":1641380014},{"date":"2021-02-05","current":-55.908703,"twenty":-58.574692,"median":-55.477214,"eighty":-51.979067,"marketCap":1566673689},{"date":"2021-02-12","current":-61.641349,"twenty":-59.021592,"median":-56.848734,"eighty":-52.040709,"marketCap":1727313880},{"date":"2021-02-19","current":-70.471472,"twenty":-59.573281,"median":-57.904342,"eighty":-52.17632,"marketCap":1974751593},{"date":"2021-02-26","current":-62.288583,"twenty":-64.649446,"median":-58.297306,"eighty":-52.641712,"marketCap":1745450675},{"date":"2021-03-05","current":-68.622232,"twenty":-66.859289,"median":-58.92913,"eighty":-53.797487,"marketCap":1922932176},{"date":"2021-03-12","current":-74.062081,"twenty":-69.115362,"median":-59.329798,"eighty":-54.429311,"marketCap":2075367626},{"date":"2021-03-19","current":-63.351896,"twenty":-69.435898,"median":-60.816896,"eighty":-55.286126,"marketCap":1775246840},{"date":"2021-03-26","current":-61.071166,"twenty":-68.856469,"median":-61.071166,"eighty":-55.748436,"marketCap":1711336226},{"date":"2021-04-01","current":-34.653954,"twenty":-68.683873,"median":-59.992443,"eighty":-54.336849,"marketCap":1795040156},{"date":"2021-04-09","current":-27.135096,"twenty":-68.159922,"median":-59.19881,"eighty":-52.016052,"marketCap":1405570837},{"date":"2021-04-16","current":-29.571374,"twenty":-67.759253,"median":-58.836668,"eighty":-38.821925,"marketCap":1531767600},{"date":"2021-04-23","current":-26.454618,"twenty":-67.207563,"median":-58.435999,"eighty":-32.103423,"marketCap":1370322776},{"date":"2021-04-30","current":-27.269511,"twenty":-66.742171,"median":-58.01992,"eighty":-29.588626,"marketCap":1412533417},{"date":"2021-05-07","current":-25.085262,"twenty":-66.252122,"median":-57.842701,"eighty":-28.74976,"marketCap":1299391492},{"date":"2021-05-14","current":-25.666496,"twenty":-65.857617,"median":-55.816241,"eighty":-27.43753,"marketCap":1203656017},{"date":"2021-05-21","current":-25.23037,"twenty":-65.632626,"median":-54.290618,"eighty":-27.279592,"marketCap":1183203438},{"date":"2021-05-28","current":-27.587308,"twenty":-65.16107,"median":-52.210223,"eighty":-27.215745,"marketCap":1293734396},{"date":"2021-06-04","current":-30.723706,"twenty":-64.778893,"median":-51.979067,"eighty":-27.125015,"marketCap":1440818898},{"date":"2021-06-11","current":-29.127669,"twenty":-64.091592,"median":-41.762192,"eighty":-27.188862,"marketCap":1365971163},{"date":"2021-06-18","current":-23.606496,"twenty":-62.926571,"median":-34.653954,"eighty":-26.976291,"marketCap":1107050220},{"date":"2021-06-25","current":-25.518028,"twenty":-62.220777,"median":-32.39833,"eighty":-26.455235,"marketCap":1196693437},{"date":"2021-07-02","current":-23.986946,"twenty":-61.940309,"median":-30.723706,"eighty":-26.30713,"marketCap":1124891831},{"date":"2021-07-09","current":-25.239649,"twenty":-61.666006,"median":-30.193045,"eighty":-25.598034,"marketCap":1183638600},{"date":"2021-07-16","current":-25.016947,"twenty":-61.527312,"median":-29.843385,"eighty":-25.527307,"marketCap":1173194730},{"date":"2021-07-23","current":-23.949829,"twenty":-60.932473,"median":-29.571374,"eighty":-25.232226,"marketCap":1123151186},{"date":"2021-07-30","current":-21.277396,"twenty":-60.300649,"median":-29.126896,"eighty":-25.016947,"marketCap":997824746},{"date":"2021-08-06","current":-25.629379,"twenty":-59.887653,"median":-28.951363,"eighty":-24.931577,"marketCap":1201915372},{"date":"2021-08-13","current":-22.380376,"twenty":-59.440752,"median":-28.633415,"eighty":-24.413811,"marketCap":1206526070},{"date":"2021-08-20","current":-22.727672,"twenty":-59.277403,"median":-28.428844,"eighty":-24.257774,"marketCap":1225248777},{"date":"2021-08-27","current":-23.131504,"twenty":-59.058577,"median":-27.914673,"eighty":-24.139127,"marketCap":1247019366},{"date":"2021-09-03","current":-23.38188,"twenty":-58.984607,"median":-27.587308,"eighty":-23.965013,"marketCap":1260517132},{"date":"2021-09-10","current":-23.220347,"twenty":-58.836668,"median":-27.513074,"eighty":-23.875524,"marketCap":1251808896},{"date":"2021-09-17","current":-21.338489,"twenty":-58.636333,"median":-27.214986,"eighty":-23.583796,"marketCap":1150357949},{"date":"2021-09-24","current":-18.616661,"twenty":-58.574692,"median":-27.118294,"eighty":-23.402351,"marketCap":1003624175},{"date":"2021-10-01","current":-19.98969,"twenty":-58.297306,"median":-26.862065,"eighty":-23.31266,"marketCap":1077644180},{"date":"2021-10-08","current":-19.238562,"twenty":-58.03533,"median":-26.455235,"eighty":-23.253883,"marketCap":1037150883},{"date":"2021-10-15","current":-20.191606,"twenty":-58.01992,"median":-26.399251,"eighty":-23.16109,"marketCap":1088529475},{"date":"2021-10-22","current":-17.938223,"twenty":-57.912047,"median":-26.295,"eighty":-22.956946,"marketCap":967049585},{"date":"2021-10-29","current":-17.946299,"twenty":-57.896637,"median":-25.647937,"eighty":-22.727672,"marketCap":967484997},{"date":"2021-11-05","current":-18.697427,"twenty":-57.788765,"median":-25.564424,"eighty":-22.146153,"marketCap":1007978293},{"date":"2021-11-12","current":-15.061427,"twenty":-55.908703,"median":-25.448433,"eighty":-21.588865,"marketCap":924801711},{"date":"2021-11-19","current":-13.851959,"twenty":-55.816241,"median":-25.23037,"eighty":-20.191606,"marketCap":850537993},{"date":"2021-11-26","current":-12.962645,"twenty":-55.545019,"median":-25.093663,"eighty":-19.655317,"marketCap":795932318},{"date":"2021-12-03","current":-11.532627,"twenty":-54.712861,"median":-25.016947,"eighty":-19.115797,"marketCap":708126393},{"date":"2021-12-10","current":-11.966613,"twenty":-54.151925,"median":-24.924154,"eighty":-18.93488,"marketCap":734773962},{"date":"2021-12-17","current":-11.141329,"twenty":-53.01156,"median":-24.696811,"eighty":-18.681274,"marketCap":684099896},{"date":"2021-12-23","current":-11.881239,"twenty":-52.425967,"median":-24.360449,"eighty":-18.48905,"marketCap":729531818},{"date":"2021-12-31","current":-10.977695,"twenty":-52.108515,"median":-24.274604,"eighty":-18.258058,"marketCap":674052452},{"date":"2022-01-07","current":-10.451221,"twenty":-52.003724,"median":-24.237487,"eighty":-17.965683,"marketCap":641725892},{"date":"2022-01-14","current":-9.73977,"twenty":-47.02021,"median":-24.135415,"eighty":-17.815458,"marketCap":598041352},{"date":"2022-01-21","current":-8.79354,"twenty":-43.092199,"median":-23.986946,"eighty":-17.447163,"marketCap":539940914},{"date":"2022-01-28","current":-9.135036,"twenty":-41.841562,"median":-23.956614,"eighty":-15.851137,"marketCap":560909493},{"date":"2022-02-04","current":-9.391159,"twenty":-38.821925,"median":-23.875524,"eighty":-14.251795,"marketCap":576635928},{"date":"2022-02-11","current":-9.675739,"twenty":-34.865658,"median":-23.638973,"eighty":-13.560264,"marketCap":594109744},{"date":"2022-02-18","current":-10.152412,"twenty":-34.576665,"median":-23.55082,"eighty":-12.62684,"marketCap":623378385},{"date":"2022-02-25","current":-10.316046,"twenty":-34.243987,"median":-23.422263,"eighty":-12.264,"marketCap":633425830},{"date":"2022-03-04","current":-9.199067,"twenty":-32.985537,"median":-23.365727,"eighty":-11.923926,"marketCap":564841102},{"date":"2022-03-11","current":-9.924747,"twenty":-31.341706,"median":-23.31266,"eighty":-11.764561,"marketCap":609399333},{"date":"2022-03-18","current":-9.068672,"twenty":-30.968679,"median":-23.264768,"eighty":-11.487094,"marketCap":594632811},{"date":"2022-03-25","current":-7.810079,"twenty":-30.630913,"median":-23.2365,"eighty":-11.193976,"marketCap":512106877},{"date":"2022-04-01","current":-7.476722,"twenty":-30.246402,"median":-23.166488,"eighty":-11.057378,"marketCap":490248656},{"date":"2022-04-08","current":-7.993765,"twenty":-30.188004,"median":-23.010354,"eighty":-10.59778,"marketCap":524151202},{"date":"2022-04-14","current":-7.619589,"twenty":-30.167842,"median":-22.956946,"eighty":-10.436992,"marketCap":499616465},{"date":"2022-04-22","current":-7.252216,"twenty":-29.88857,"median":-22.768055,"eighty":-10.316046,"marketCap":475527814},{"date":"2022-04-29","current":-6.699959,"twenty":-29.7982,"median":-22.622892,"eighty":-10.209328,"marketCap":439316344},{"date":"2022-05-06","current":-7.041446,"twenty":-29.600128,"median":-22.263264,"eighty":-10.059923,"marketCap":461707595},{"date":"2022-05-13","current":-7.253167,"twenty":-29.571374,"median":-21.928084,"eighty":-9.924747,"marketCap":475590171},{"date":"2022-05-20","current":-6.544416,"twenty":-29.520968,"median":-21.495984,"eighty":-9.689968,"marketCap":507833572},{"date":"2022-05-27","current":-6.625211,"twenty":-29.127669,"median":-21.277396,"eighty":-9.590365,"marketCap":514103122},{"date":"2022-06-03","current":-6.665609,"twenty":-29.126432,"median":-19.98969,"eighty":-9.496453,"marketCap":517237898},{"date":"2022-06-10","current":-6.971476,"twenty":-29.112513,"median":-19.577781,"eighty":-9.352741,"marketCap":540972624},{"date":"2022-06-17","current":-7.040729,"twenty":-28.982912,"median":-19.238562,"eighty":-9.13219,"marketCap":546346524},{"date":"2022-06-24","current":-7.727489,"twenty":-28.844515,"median":-19.109336,"eighty":-9.06676,"marketCap":599637701},{"date":"2022-07-01","current":-7.462019,"twenty":-28.737999,"median":-18.980109,"eighty":-8.81167,"marketCap":579037750},{"date":"2022-07-08","current":-8.218032,"twenty":-28.649627,"median":-18.867037,"eighty":-8.717851,"marketCap":637702828},{"date":"2022-07-15","current":-8.495044,"twenty":-28.533795,"median":-18.697427,"eighty":-8.386127,"marketCap":659198429},{"date":"2022-07-22","current":-8.396936,"twenty":-28.475112,"median":-18.548009,"eighty":-8.431562,"marketCap":651585404},{"date":"2022-07-29","current":-7.796742,"twenty":-28.344626,"median":-18.382438,"eighty":-8.277293,"marketCap":605011602},{"date":"2022-08-05","current":-8.546984,"twenty":-28.099524,"median":-18.253212,"eighty":-8.229013,"marketCap":663228854},{"date":"2022-08-12","current":5.525032,"twenty":-27.916011,"median":-18.196675,"eighty":-8.169153,"marketCap":623974964},{"date":"2022-08-19","current":5.315016,"twenty":-27.790849,"median":-17.942261,"eighty":-8.044899,"marketCap":600256617},{"date":"2022-08-26","current":5.173659,"twenty":-27.604011,"median":-17.905916,"eighty":-7.905239,"marketCap":584292346},{"date":"2022-09-02","current":5.331171,"twenty":-27.567722,"median":-17.603042,"eighty":-7.802077,"marketCap":602081106},{"date":"2022-09-09","current":5.476566,"twenty":-27.533288,"median":-17.215364,"eighty":-7.757032,"marketCap":618501499},{"date":"2022-09-16","current":5.044418,"twenty":-27.467722,"median":-16.000542,"eighty":-7.692862,"marketCap":569696440},{"date":"2022-09-23","current":4.773821,"twenty":-27.282953,"median":-14.986725,"eighty":-7.619589,"marketCap":539136263},{"date":"2022-09-30","current":5.177698,"twenty":-27.247701,"median":-14.001364,"eighty":-7.542033,"marketCap":584748468},{"date":"2022-10-07","current":5.092884,"twenty":-27.155388,"median":-13.666982,"eighty":-7.496604,"marketCap":575169905},{"date":"2022-10-14","current":5.096922,"twenty":-27.131736,"median":-13.168966,"eighty":-7.411233,"marketCap":575626027},{"date":"2022-10-21","current":4.959604,"twenty":-27.095178,"median":-12.656721,"eighty":-7.277453,"marketCap":560117877},{"date":"2022-10-28","current":5.500799,"twenty":-26.993906,"median":-12.400598,"eighty":-7.19113,"marketCap":621238232},{"date":"2022-11-04","current":5.024225,"twenty":-26.920032,"median":-11.991513,"eighty":-7.112385,"marketCap":567415830},{"date":"2022-11-11","current":4.963643,"twenty":-26.735211,"median":-11.923926,"eighty":-7.040872,"marketCap":560573999},{"date":"2022-11-18","current":5.385148,"twenty":-26.582437,"median":-11.831437,"eighty":-6.949546,"marketCap":568036129},{"date":"2022-11-25","current":5.762672,"twenty":-26.455235,"median":-11.753177,"eighty":-6.873368,"marketCap":607858162},{"date":"2022-12-02","current":5.254967,"twenty":-26.455235,"median":-11.532627,"eighty":-6.625211,"marketCap":554304393},{"date":"2022-12-09","current":5.055356,"twenty":-26.454618,"median":-11.326306,"eighty":-6.469392,"marketCap":533249065},{"date":"2022-12-16","current":4.964229,"twenty":-26.343884,"median":-11.169787,"eighty":-6.232777,"marketCap":523636850},{"date":"2022-12-23","current":4.443506,"twenty":-26.325326,"median":-11.105757,"eighty":-6.094271,"marketCap":468709908},{"date":"2022-12-30","current":4.578026,"twenty":-26.301065,"median":-11.016825,"eighty":-3.150451,"marketCap":482899368},{"date":"2023-01-06","current":4.716886,"twenty":-26.263087,"median":-10.952794,"eighty":4.412263,"marketCap":497546553},{"date":"2023-01-13","current":4.764619,"twenty":-25.896622,"median":-10.472565,"eighty":4.513804,"marketCap":502581522},{"date":"2023-01-20","current":3.966661,"twenty":-25.651649,"median":-10.436992,"eighty":4.53984,"marketCap":418411296},{"date":"2023-01-27","current":4.27609,"twenty":-25.609995,"median":-10.344504,"eighty":4.516407,"marketCap":451050523},{"date":"2023-02-03","current":4.387932,"twenty":-25.574321,"median":-10.280473,"eighty":4.484296,"marketCap":462847834},{"date":"2023-02-10","current":4.231353,"twenty":-25.545866,"median":-10.209328,"eighty":4.447845,"marketCap":446331599},{"date":"2023-02-17","current":4.227625,"twenty":-25.510604,"median":-10.152412,"eighty":4.446109,"marketCap":445938355},{"date":"2023-02-24","current":4.100871,"twenty":-25.479055,"median":-10.059923,"eighty":4.44283,"marketCap":432568070},{"date":"2023-03-03","current":4.287274,"twenty":-25.365847,"median":-9.946091,"eighty":4.430387,"marketCap":452230255},{"date":"2023-03-10","current":3.850903,"twenty":-25.237793,"median":-9.789572,"eighty":4.390734,"marketCap":428274275},{"date":"2023-03-17","current":4.031248,"twenty":-25.211811,"median":-9.714869,"eighty":4.386029,"marketCap":448331197},{"date":"2023-03-24","current":3.716528,"twenty":-25.128794,"median":-9.66151,"eighty":4.370626,"marketCap":413329901},{"date":"2023-03-31","current":3.617515,"twenty":-25.091983,"median":-9.576136,"eighty":4.334993,"marketCap":402318258},{"date":"2023-04-06","current":3.536182,"twenty":-25.085262,"median":-9.512105,"eighty":4.317099,"marketCap":393272980},{"date":"2023-04-14","current":3.606906,"twenty":-25.016947,"median":-9.44096,"eighty":4.305914,"marketCap":401138439},{"date":"2023-04-21","current":3.710993,"twenty":-25.016947,"median":-9.391159,"eighty":4.305914,"marketCap":412714374},{"date":"2023-04-28","current":3.420906,"twenty":-24.972406,"median":-9.152822,"eighty":4.291002,"marketCap":380452621},{"date":"2023-05-05","current":3.396142,"twenty":-24.931577,"median":-9.120807,"eighty":4.278327,"marketCap":377698569},{"date":"2023-05-12","current":5.794216,"twenty":-24.827649,"median":-9.066281,"eighty":4.278327,"marketCap":378652011},{"date":"2023-05-19","current":5.300322,"twenty":-24.781253,"median":-8.907372,"eighty":4.321573,"marketCap":346376060},{"date":"2023-05-26","current":5.758077,"twenty":-24.649487,"median":-8.823876,"eighty":4.401172,"marketCap":376290356},{"date":"2023-06-02","current":6.119463,"twenty":-24.464843,"median":-8.800111,"eighty":4.447845,"marketCap":399906906},{"date":"2023-06-09","current":7.830022,"twenty":-24.359983,"median":-8.721708,"eighty":4.553726,"marketCap":511691908},{"date":"2023-06-16","current":7.649329,"twenty":-24.335847,"median":-8.650275,"eighty":4.643117,"marketCap":499883633},{"date":"2023-06-23","current":7.462613,"twenty":-24.302442,"median":-8.521014,"eighty":4.676219,"marketCap":487681749},{"date":"2023-06-30","current":6.625403,"twenty":-24.270397,"median":-8.440219,"eighty":4.720357,"marketCap":432970076},{"date":"2023-07-07","current":6.312202,"twenty":-24.253567,"median":-8.382507,"eighty":4.781976,"marketCap":412502399},{"date":"2023-07-14","current":6.938604,"twenty":-24.246766,"median":-8.313516,"eighty":4.899023,"marketCap":453437752},{"date":"2023-07-21","current":6.583241,"twenty":-24.228208,"median":-8.252287,"eighty":4.955566,"marketCap":430214811},{"date":"2023-07-28","current":5.992978,"twenty":-24.153973,"median":-8.197862,"eighty":4.964229,"marketCap":391641114},{"date":"2023-08-04","current":6.029117,"twenty":-24.135415,"median":-8.143007,"eighty":5.024225,"marketCap":394002769},{"date":"2023-08-11","current":-3.101956,"twenty":-24.043543,"median":-8.079526,"eighty":5.037999,"marketCap":439739486},{"date":"2023-08-18","current":-3.038651,"twenty":-23.986946,"median":-7.961621,"eighty":5.024225,"marketCap":430765211},{"date":"2023-08-25","current":-3.349148,"twenty":-23.971475,"median":-7.900622,"eighty":5.024225,"marketCap":474781894},{"date":"2023-09-01","current":-3.120043,"twenty":-23.963398,"median":-7.814953,"eighty":5.00807,"marketCap":442303565},{"date":"2023-09-08","current":-3.195407,"twenty":-23.952543,"median":-7.796742,"eighty":4.991915,"marketCap":452987226},{"date":"2023-09-15","current":-2.906011,"twenty":-23.905288,"median":-7.750573,"eighty":4.97243,"marketCap":411961968},{"date":"2023-09-22","current":-2.896968,"twenty":-23.87925,"median":-7.721718,"eighty":4.965097,"marketCap":410679928},{"date":"2023-09-29","current":-2.921084,"twenty":-23.868287,"median":-7.675549,"eighty":4.96376,"marketCap":414098700},{"date":"2023-10-06","current":-2.601543,"twenty":-23.710456,"median":-7.619589,"eighty":4.963643,"marketCap":368799977},{"date":"2023-10-13","current":-2.628674,"twenty":-23.619487,"median":-7.55836,"eighty":4.960412,"marketCap":372646095},{"date":"2023-10-20","current":-2.580442,"twenty":-23.588336,"median":-7.537951,"eighty":4.956374,"marketCap":365808552},{"date":"2023-10-27","current":-2.562354,"twenty":-23.577201,"median":-7.537951,"eighty":4.95395,"marketCap":363244474},{"date":"2023-11-03","current":-2.833662,"twenty":-23.525109,"median":-7.490874,"eighty":4.945065,"marketCap":401705653},{"date":"2023-11-10","current":-2.627538,"twenty":-23.422263,"median":-7.46779,"eighty":4.934564,"marketCap":410266375},{"date":"2023-11-17","current":-2.457666,"twenty":-23.418281,"median":-7.346597,"eighty":4.924871,"marketCap":383742376},{"date":"2023-11-24","current":-2.400128,"twenty":-23.402351,"median":-7.300975,"eighty":4.899023,"marketCap":374758441},{"date":"2023-12-01","current":-2.243956,"twenty":-23.38188,"median":-7.252692,"eighty":4.894984,"marketCap":350373474},{"date":"2023-12-08","current":-2.219297,"twenty":-23.349573,"median":-7.190987,"eighty":4.882868,"marketCap":346523216},{"date":"2023-12-15","current":-2.331632,"twenty":-23.33342,"median":-7.139553,"eighty":4.789976,"marketCap":364063280},{"date":"2023-12-22","current":-2.597399,"twenty":-23.31266,"median":-7.102546,"eighty":4.781976,"marketCap":405560505},{"date":"2023-12-29","current":-2.80289,"twenty":-23.29604,"median":-7.064172,"eighty":4.777083,"marketCap":437645988},{"date":"2024-01-05","current":-2.865907,"twenty":-23.281729,"median":-7.040729,"eighty":4.771981,"marketCap":447485536},{"date":"2024-01-12","current":-2.852207,"twenty":-23.267192,"median":-6.96282,"eighty":4.75594,"marketCap":445346504},{"date":"2024-01-19","current":-2.890566,"twenty":-23.26073,"median":-6.945507,"eighty":4.721225,"marketCap":451335794},{"date":"2024-01-26","current":-3.561834,"twenty":-23.253883,"median":-6.873368,"eighty":4.716886,"marketCap":556148372},{"date":"2024-02-02","current":-4.797517,"twenty":-23.2365,"median":-6.682784,"eighty":4.712546,"marketCap":749089076},{"date":"2024-02-09","current":-4.929031,"twenty":-23.220347,"median":-6.561729,"eighty":4.68093,"marketCap":769623785},{"date":"2024-02-16","current":-5.049585,"twenty":-23.171887,"median":-6.506904,"eighty":4.669153,"marketCap":788447268},{"date":"2024-02-23","current":-4.805736,"twenty":-23.163249,"median":-6.426108,"eighty":4.668881,"marketCap":750372495},{"date":"2024-03-01","current":-5.060545,"twenty":-23.137421,"median":-6.232777,"eighty":4.658671,"marketCap":790158494},{"date":"2024-03-08","current":-4.479692,"twenty":-23.034584,"median":-6.129168,"eighty":4.638777,"marketCap":699463529},{"date":"2024-03-15","current":-4.754705,"twenty":-22.971586,"median":-6.023817,"eighty":4.599723,"marketCap":728240056},{"date":"2024-03-22","current":-4.594434,"twenty":-22.957936,"median":-5.1674,"eighty":4.58063,"marketCap":703692639},{"date":"2024-03-28","current":-4.98527,"twenty":-22.956946,"median":-5.066025,"eighty":4.565008,"marketCap":763553885},{"date":"2024-04-05","current":-4.690034,"twenty":-22.858149,"median":-5.049585,"eighty":4.553726,"marketCap":718334958},{"date":"2024-04-12","current":-4.884046,"twenty":-22.763209,"median":-4.994788,"eighty":4.533765,"marketCap":748050253},{"date":"2024-04-19","current":-5.078058,"twenty":-22.734133,"median":-4.994788,"eighty":4.513804,"marketCap":777765548},{"date":"2024-04-26","current":-5.412659,"twenty":-22.664804,"median":-4.993658,"eighty":4.472145,"marketCap":829013666},{"date":"2024-05-03","current":-7.754864,"twenty":-22.500405,"median":-5.013967,"eighty":4.447845,"marketCap":1187750489},{"date":"2024-05-10","current":-7.639581,"twenty":-22.395724,"median":-5.055065,"eighty":4.445242,"marketCap":1170093574},{"date":"2024-05-17","current":-10.368658,"twenty":-22.239842,"median":-5.071504,"eighty":4.441477,"marketCap":1372271111},{"date":"2024-05-24","current":-9.863507,"twenty":-22.137115,"median":-5.1674,"eighty":4.41091,"marketCap":1305415400},{"date":"2024-05-31","current":-9.924473,"twenty":-22.049888,"median":-5.362047,"eighty":4.390033,"marketCap":1313484192},{"date":"2024-06-07","current":-9.815605,"twenty":-21.837626,"median":-6.023817,"eighty":4.384126,"marketCap":1299075634},{"date":"2024-06-14","current":-9.493353,"twenty":-21.679323,"median":-6.111584,"eighty":4.370626,"marketCap":1256426301},{"date":"2024-06-21","current":-7.625166,"twenty":-21.588865,"median":-6.169295,"eighty":4.339467,"marketCap":1009175437},{"date":"2024-06-28","current":-7.442266,"twenty":-21.51456,"median":-6.232777,"eighty":4.33052,"marketCap":984969059},{"date":"2024-07-05","current":-7.307269,"twenty":-21.390179,"median":-6.388596,"eighty":4.314862,"marketCap":967102446},{"date":"2024-07-12","current":-7.045984,"twenty":-21.32627,"median":-6.506904,"eighty":4.305914,"marketCap":932521906},{"date":"2024-07-15","current":-7.163562,"twenty":-21.314052,"median":-6.544416,"eighty":4.305914,"marketCap":948083149},{"date":"2024-08-02","current":-8.169509,"twenty":-21.301833,"median":-6.544416,"eighty":4.305914,"marketCap":1081218229},{"date":"2024-08-09","current":-6.680107,"twenty":-20.625922,"median":-6.625211,"eighty":4.29473,"marketCap":949657379},{"date":"2024-08-16","current":-6.896252,"twenty":-20.070456,"median":-6.645442,"eighty":4.280564,"marketCap":980384999},{"date":"2024-08-23","current":-7.283682,"twenty":-19.824926,"median":-6.680107,"eighty":4.26938,"marketCap":1035462808},{"date":"2024-08-30","current":-7.691503,"twenty":-19.710238,"median":-6.763232,"eighty":4.255959,"marketCap":1093439449},{"date":"2024-09-06","current":-7.31223,"twenty":-19.603626,"median":-6.856262,"eighty":4.249994,"marketCap":1039521173},{"date":"2024-09-13","current":-7.185805,"twenty":-19.383942,"median":-6.939269,"eighty":4.247011,"marketCap":1021548414},{"date":"2024-09-20","current":-7.316308,"twenty":-19.267638,"median":-6.945507,"eighty":4.238063,"marketCap":1040100939},{"date":"2024-09-27","current":-7.055302,"twenty":-19.190102,"median":-6.948392,"eighty":4.229862,"marketCap":1002995889},{"date":"2024-10-04","current":-6.565917,"twenty":-19.114182,"median":-6.940945,"eighty":4.226134,"marketCap":933423920},{"date":"2024-10-11","current":-6.472118,"twenty":-19.093183,"median":-6.896252,"eighty":4.222406,"marketCap":920089292},{"date":"2024-10-18","current":-7.08385,"twenty":-19.049569,"median":-6.88481,"eighty":4.219245,"marketCap":1007054254},{"date":"2024-10-25","current":-6.46804,"twenty":-18.988186,"median":-6.839157,"eighty":4.217292,"marketCap":919509526},{"date":"2024-10-31","current":-6.614856,"twenty":-18.93488,"median":-6.835079,"eighty":4.216441,"marketCap":940381117},{"date":"2024-11-08","current":-6.292896,"twenty":-18.896112,"median":-6.798375,"eighty":4.21495,"marketCap":903276066},{"date":"2024-11-15","current":-6.206551,"twenty":-18.795962,"median":-6.724967,"eighty":4.198546,"marketCap":890882172},{"date":"2024-11-22","current":-4.957128,"twenty":-18.703889,"median":-6.705868,"eighty":4.156792,"marketCap":711541186},{"date":"2024-11-29","current":-5.456086,"twenty":-18.697427,"median":-6.672858,"eighty":4.156792,"marketCap":783161125},{"date":"2024-12-06","current":-5.046372,"twenty":-18.616661,"median":-6.663794,"eighty":4.149336,"marketCap":724351256},{"date":"2024-12-13","current":-4.949015,"twenty":-18.568201,"median":-6.634307,"eighty":4.138152,"marketCap":710376634},{"date":"2024-12-20","current":-4.441944,"twenty":-18.527818,"median":-6.623012,"eighty":4.123239,"marketCap":637592143},{"date":"2024-12-27","current":-5.232975,"twenty":-18.450282,"median":-6.614856,"eighty":4.123239,"marketCap":751135949},{"date":"2025-01-03","current":-5.02609,"twenty":-18.401822,"median":-6.606699,"eighty":4.123239,"marketCap":721439877},{"date":"2025-01-10","current":-4.514962,"twenty":-18.369515,"median":-6.569995,"eighty":4.121748,"marketCap":648073110},{"date":"2025-01-17","current":-4.113361,"twenty":-18.321055,"median":-6.553072,"eighty":4.116529,"marketCap":590427793},{"date":"2025-01-24","current":-4.283737,"twenty":-18.26775,"median":-6.542932,"eighty":4.109818,"marketCap":614883382},{"date":"2025-01-31","current":-4.454113,"twenty":-18.227367,"median":-6.508822,"eighty":4.100871,"marketCap":639338971},{"date":"2025-02-07","current":-4.198549,"twenty":-18.216059,"median":-6.498624,"eighty":4.100125,"marketCap":602655587},{"date":"2025-02-14","current":-3.89025,"twenty":-18.153061,"median":-6.472118,"eighty":4.085378,"marketCap":558402616},{"date":"2025-02-21","current":-3.711761,"twenty":-17.978606,"median":-6.46804,"eighty":4.03832,"marketCap":532782475},{"date":"2025-02-28","current":-2.995164,"twenty":-17.946299,"median":-6.420369,"eighty":4.031248,"marketCap":501339575},{"date":"2025-03-07","current":-2.974879,"twenty":-17.938223,"median":-6.366085,"eighty":3.966661,"marketCap":497944149},{"date":"2025-03-14","current":-3.118204,"twenty":-17.922069,"median":-6.285921,"eighty":3.96406,"marketCap":521934407},{"date":"2025-03-21","current":-3.04829,"twenty":-17.905916,"median":-6.206551,"eighty":3.914554,"marketCap":510231842},{"date":"2025-03-28","current":-2.897972,"twenty":-17.67977,"median":-6.129168,"eighty":3.907012,"marketCap":485071327},{"date":"2025-04-04","current":-2.618313,"twenty":-17.647464,"median":-6.023817,"eighty":3.892099,"marketCap":438261066},{"date":"2025-04-11","current":-2.649775,"twenty":-17.55862,"median":-5.539245,"eighty":3.889801,"marketCap":443527221},{"date":"2025-04-17","current":-2.660262,"twenty":-17.41001,"median":-5.456086,"eighty":3.867169,"marketCap":445282605},{"date":"2025-04-25","current":-2.845536,"twenty":-17.120867,"median":-5.342502,"eighty":3.855853,"marketCap":476294403},{"date":"2025-04-30","current":-2.761638,"twenty":-16.637784,"median":-5.312771,"eighty":3.853025,"marketCap":462251325}],"updateTime":1746151986232}}}